Get the Stockscreener App
0.4301
3.00%
-0.0133
Cadrenal Therapeutics Inc Stock (CVKD) Forecast
The Cadrenal Therapeutics Inc (CVKD) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.6306, representing a +46.62% increase from the current price of $0.4301. The highest analyst price target is $0.9582, and the lowest is $0.303.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CVKD Price Target
Average 1.1745
(+173.09% Upside)
Is Cadrenal Therapeutics Inc (CVKD) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 39.47 | Neutral |
| STOCH(9,6) | 20.39 | Neutral |
| STOCHRSI(14) | 28.97 | Neutral |
| MACD(12,26) | -0.0179 | Buy |
| ADX(14) | 22.71 | Neutral |
| William %R | -90.00 | Buy |
| CCI(14) | -94.18 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.4661
Sell
|
0.4522
Sell
|
| MA20 |
0.4495
Sell
|
0.4611
Sell
|
| MA50 |
0.514
Sell
|
0.528
Sell
|
| MA100 |
0.7052
Sell
|
0.613
Sell
|
| MA200 |
0.6655
Sell
|
0.7884
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, CVKD could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 10 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on CVKD, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 39.47 indicates that CVKD is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 20.39 indicates that CVKD is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 28.97 indicates that CVKD is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 22.71 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -94.18 indicates that CVKD is still oversold but not to an extreme extent.
Long-term CVKD price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Cadrenal Therapeutics Inc financial reports and earnings history, Cadrenal Therapeutics Inc (CVKD) stock could reach $2.9011 by 2030, $11.10 by 2040 and $9.5657 by 2050. See the projected annual prices until 2050 of the Cadrenal Therapeutics Inc stock below:
- Cadrenal Therapeutics Inc (CVKD) is expected to reach an average price of $5.8603 in 2035, with a high prediction of $6.2027 and a low estimate of $5.9384. This indicates an $1,263% rise from the last recorded price of $0.4301.
- Cadrenal Therapeutics Inc (CVKD) stock is projected to chart a bullish course in 2040, with an average price target of $10.81, representing an $2,414% surge from its current level. The forecast ranges from a conservative $10.81 to a sky-high $11.10.
- Our analysts predict Cadrenal Therapeutics Inc (CVKD) to jump 1,166% by 2045, soaring from $5.4568 to an average price of $5.4468, potentially reaching $5.8265. While $5.4568 is the low estimate, the potential upside is significant.
- Cadrenal Therapeutics Inc (CVKD) stock is expected to climb by 2050, reaching an average of $8.2339, a $1,814% jump from its current level. However, a wide range of estimates exists, with high and low targets of $9.5657 and $8.7239, respectively, highlighting the market's uncertainty.
Cadrenal Therapeutics Inc Stock (CVKD) Year by Year Forecast
Cadrenal Therapeutics Inc Stock (CVKD) Price Forecast for 2024
Our forecast for CVKD stock price in 2024 now indicates an average price target of $1.1745 with a high forecast of $2.3406 and a low forecast of $0.00843. The average prediction reflects an increase of +173.09% from the last recorded price of $0.4301.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $0.473 | $0.303 | $0.9582 | +9.98% |
| July, 2024 | $0.5119 | $0.4131 | $0.7223 | +19.03% |
| August, 2024 | $0.6911 | $0.5417 | $0.8811 | +60.68% |
| September, 2024 | $0.0774 | $0.0478 | $2.3406 | -82.00% |
| October, 2024 | $0.0197 | $0.0208 | $0.1798 | -95.41% |
| November, 2024 | $0.1083 | $0.0088 | $0.2755 | -74.82% |
| December, 2024 | $0.0325 | $0.00843 | $0.1236 | -92.45% |
Cadrenal Therapeutics Inc Stock (CVKD) Price Forecast for 2025
Cadrenal Therapeutics Inc Stock (CVKD) is expected to reach an average price of $0.8522 in 2025, with a high prediction of $1.7034 and a low estimate of $0.00102. This indicates an +98.14% rise from the last recorded price of $0.4301.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $0.1815 | $0.1228 | $0.1531 | -57.79% |
| February, 2025 | $0.0645 | $0.0931 | $0.0645 | -85.01% |
| March, 2025 | $0.2146 | $0.0183 | $0.2517 | -50.11% |
| April, 2025 | $1.3436 | $0.0444 | $1.3736 | +212.39% |
| May, 2025 | $0.1927 | $0.1641 | $1.7034 | -55.19% |
| June, 2025 | $0.1899 | $0.1219 | $0.3325 | -55.85% |
| July, 2025 | $0.0524 | $0.00102 | $0.2715 | -87.81% |
| August, 2025 | $0.521 | $0.0566 | $0.221 | +21.13% |
| September, 2025 | $0.5127 | $0.5127 | $0.4803 | +19.21% |
| October, 2025 | $0.3548 | $0.4049 | $0.3672 | -17.52% |
| November, 2025 | $0.1561 | $0.3066 | $0.2507 | -63.72% |
| December, 2025 | $0.3088 | $0.1374 | $1.5413 | -28.20% |
Cadrenal Therapeutics Inc Stock (CVKD) Price Forecast for 2026
The predicted value for Cadrenal Therapeutics Inc (CVKD) in 2026 is set at an average of $0.7368. Estimates vary from a peak of $1.446 to a trough of $0.0276, indicating an +71.31% surge from the present price of $0.4301.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.6305 | $0.4191 | $0.66 | +46.60% |
| February, 2026 | $0.6721 | $0.7517 | $0.6792 | +56.27% |
| March, 2026 | $0.6588 | $0.603 | $0.5583 | +53.18% |
| April, 2026 | $0.7984 | $0.6806 | $0.696 | +85.62% |
| May, 2026 | $0.7215 | $0.7873 | $0.7763 | +67.75% |
| June, 2026 | $0.5907 | $0.6576 | $0.629 | +37.34% |
| July, 2026 | $0.2625 | $0.4115 | $0.5298 | -38.96% |
| August, 2026 | $0.4168 | $0.0276 | $1.2368 | -3.10% |
| September, 2026 | $0.143 | $0.1554 | $0.5262 | -66.76% |
| October, 2026 | $0.1471 | $0.1571 | $0.1267 | -65.80% |
| November, 2026 | $0.2483 | $0.2176 | $0.2684 | -42.27% |
| December, 2026 | $1.4578 | $0.2086 | $1.446 | +238.94% |
Cadrenal Therapeutics Inc Stock (CVKD) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Cadrenal Therapeutics Inc (CVKD) is $0.7454, with a high forecast of $1.43 and a low forecast of $0.0608. This indicates an +73.30% increase from the last price of $0.4301.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.4104 | $1.3997 | $1.3384 | +227.91% |
| February, 2027 | $1.2429 | $1.2923 | $1.2742 | +188.98% |
| March, 2027 | $0.8861 | $0.9661 | $1.1186 | +106.03% |
| April, 2027 | $1.1709 | $1.0374 | $0.9387 | +172.24% |
| May, 2027 | $1.4943 | $1.47 | $1.43 | +247.42% |
| June, 2027 | $1.1745 | $1.3045 | $1.4198 | +173.07% |
| July, 2027 | $1.3545 | $1.3527 | $1.2745 | +214.94% |
| August, 2027 | $1.4286 | $1.3576 | $1.3995 | +232.16% |
| September, 2027 | $1.2628 | $1.2727 | $1.3602 | +193.61% |
| October, 2027 | $1.0694 | $1.1473 | $1.1935 | +148.63% |
| November, 2027 | $0.4579 | $0.7607 | $0.8013 | +6.47% |
| December, 2027 | $0.5412 | $0.0608 | $0.7701 | +25.82% |
Cadrenal Therapeutics Inc Stock (CVKD) Price Forecast for 2028
In 2028, Cadrenal Therapeutics Inc (CVKD) is projected to reach an average price of $1.4701, with a high projection of $2.4118 and a low estimate of $0.5284. This indicates an +241.80% rise from the last price of $0.4301.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.5541 | $0.5731 | $0.5237 | +28.83% |
| February, 2028 | $0.5473 | $0.5356 | $0.515 | +27.25% |
| March, 2028 | $0.573 | $0.5284 | $0.6176 | +33.22% |
| April, 2028 | $2.3446 | $2.4819 | $2.4118 | +445.12% |
| May, 2028 | $2.1888 | $2.2785 | $2.2254 | +408.92% |
| June, 2028 | $2.0623 | $2.1022 | $2.017 | +379.49% |
| July, 2028 | $1.7657 | $1.7948 | $1.7832 | +310.53% |
| August, 2028 | $2.23 | $1.8465 | $2.20 | +418.48% |
| September, 2028 | $2.2123 | $2.2134 | $2.1604 | +414.37% |
| October, 2028 | $1.9668 | $2.006 | $2.0952 | +357.29% |
| November, 2028 | $2.0451 | $2.0101 | $1.9466 | +375.49% |
| December, 2028 | $1.9924 | $2.0195 | $2.0227 | +363.24% |
Cadrenal Therapeutics Inc Stock (CVKD) Price Forecast for 2029
The 2029 price forecast for Cadrenal Therapeutics Inc Stock (CVKD) is $1.8966 on average, with a high prediction of $3.3775 and a low estimate of $0.4156. This represents an +340.96% increase from the previous price of $0.4301.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.7001 | $1.7788 | $1.8156 | +295.28% |
| February, 2029 | $1.4699 | $1.5022 | $1.6196 | +241.76% |
| March, 2029 | $0.0856 | $0.4156 | $1.2454 | -80.09% |
| April, 2029 | $1.1191 | $0.8459 | $0.9491 | +160.19% |
| May, 2029 | $0.9033 | $0.9908 | $0.9499 | +110.03% |
| June, 2029 | $0.9952 | $0.9142 | $0.9668 | +131.38% |
| July, 2029 | $3.4475 | $0.8482 | $3.1475 | +701.56% |
| August, 2029 | $2.9728 | $3.2528 | $3.3775 | +591.20% |
| September, 2029 | $3.017 | $3.0671 | $3.0882 | +601.47% |
| October, 2029 | $2.6525 | $2.6825 | $2.8543 | +516.71% |
| November, 2029 | $2.7069 | $2.6235 | $2.4857 | +529.35% |
| December, 2029 | $2.9111 | $2.7878 | $2.97 | +576.85% |
Cadrenal Therapeutics Inc Stock (CVKD) Price Forecast for 2030
Cadrenal Therapeutics Inc Stock (CVKD) is expected to reach an average price of $2.6176 in 2030, with a high forecast of $4.3432 and a low forecast of $0.892. This signifies an +508.61% surge from the last price of $0.4301.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $2.6654 | $2.8114 | $2.9011 | +519.71% |
| February, 2030 | $2.6806 | $2.697 | $2.6188 | +523.24% |
| March, 2030 | $2.6973 | $2.6627 | $2.5949 | +527.14% |
| April, 2030 | $2.503 | $2.5688 | $2.6459 | +481.96% |
| May, 2030 | $2.2146 | $2.2742 | $2.3224 | +414.89% |
| June, 2030 | $1.7798 | $1.9288 | $2.0276 | +313.82% |
| July, 2030 | $1.2642 | $0.892 | $1.3999 | +193.93% |
| August, 2030 | $1.3961 | $1.4085 | $1.3863 | +224.59% |
| September, 2030 | $1.2827 | $1.2927 | $1.3395 | +198.24% |
| October, 2030 | $1.2081 | $1.2281 | $1.3159 | +180.89% |
| November, 2030 | $4.3256 | $1.1681 | $4.3432 | +905.71% |
| December, 2030 | $4.1607 | $4.1794 | $4.1769 | +867.38% |
4.27%
2.59%
Cap:
|
Volume (24h):